Registration successful.
Account activated – Pending validation
Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website.
Important supply updates
At this time, COVID-19 is not having an impact on GSK supply in the UK.
In our response to coronavirus (COVID-19), we have been actively exploring ways to manage all parts of our supply chains to develop contingency plans to help us respond to the situation and support patients who depend on our products. Our focus is to avoid or minimise any potential delivery delays or disruptions, closely monitor what is happening and keep our customers informed. We will inform you, should this change.
Please see below for details of products where we are currently experiencing supply issues:
Product name |
PIP code |
Status |
Estimated recovery date |
|---|---|---|---|
CUTIVATE Cream 15gm |
2075216 |
Out of stock |
TBC |
CUTIVATE Ointment 15gm |
2247146 |
Out of stock |
TBC |
ENGERIX B Vials |
153171 |
Being Discontinued |
No Replenishment |
FLIXOTIDE Nebules 0.5mg/2ml x 10 |
2589588 |
Out of stock |
Early Dec 2020 |
FORTUM Injection 1gm |
381988 |
Out of stock |
Q1 2021 |
FORTUM Injection 2gm |
385278 |
Out of stock |
Q1 2021 |
FORTUM Injection 3gm |
2075208 |
Being Discontinued |
No Replenishment |
FORTUM Injection 500mg |
434092 |
Out of stock |
Q1 2021 |
TIMENTIN Vials 3.2g x 4 |
4192 |
Not marketed in the UK |
|
ZANTAC Syrup 300ml |
413229 |
Out of stock |
TBC |
ZANTAC Inj 25mg/ml 5x2ml |
453720 |
Out of stock |
TBC |
Zyban Tablets 150mg x 60 |
2709848 |
Out of stock |
Early Dec 2020 |
If you have any queries about the availability of a product, please contact your wholesaler.
Further information
If you require further information, please contact our UK Customer Contact Centre (customercontactuk@gsk.com); Freephone: 0800 221 441 or chat to a member of our team online.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.
